Outcome and cost comparison of percutaneous transluminal renal angioplasty, renal arterial stent placement, and renal arterial bypass grafting

被引:35
作者
Xue, FY [1 ]
Bettmann, MA [1 ]
Langdon, DR [1 ]
Wivell, WA [1 ]
机构
[1] Dartmouth Hitchcock Med Ctr, Dept Radiol, Lebanon, NH 03756 USA
关键词
arteries; transluminal angioplasty; cost-effectiveness; grafts; hypertension; renovascular; renal arteries; stenosis or obstruction; stents and prostheses;
D O I
10.1148/radiology.212.2.r99au20378
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PURPOSE: To compare the outcomes and costs of percutaneous transluminal renal angioplasty (PTRA), percutaneous transluminal stent placement (PTSP) of renal arteries, and renal arterial bypass grafting (RABG) in treatment of renovascular hypertension. MATERIALS AND METHODS: Medical records and angiograms of 130 patients who underwent PTRA, PTSP, or RABG were retrospectively studied to determine success and complication rates, angiographic stenoses, blood pressures, antihypertensive medications, and serum creatinine levels. Actual costs were analyzed in detail. RESULTS: Technical success rates for PTRA, PTSP, and RABG were 91%, 98%, and 92%, respectively, Complication rates were 13%, 16%, and 38%, respectively. The :mean arterial pressure was initially lowered by 29.2 mm Hg, 30.3 mm Hg, and 27.3 mm Hg, respectively, and maintained at 21.0 mm Hg, 19.8 mm Hg, and 20.2 mm Hg below baseline at 12 months. The number of antihypertensive medications was initially reduced on average by 0.63, 0.75 and 0.58, respectively, but returned to baseline in all patients by 12 months. The serum creatinine level did not change substantially with any treatment, initial treatment costs were $1,402, $2,573, and $15,393, respectively. CONCLUSION: PTRA, PTSP, and RABG were equally efficacious for control of renovascular hypertension,The initial treatment. cost for bypass grafting was substantially higher than that for PTRA and PTSP of renal arteries.
引用
收藏
页码:378 / 384
页数:7
相关论文
共 19 条
[1]   Treatment of ostial renal-artery stenoses with vascular endoprostheses after unsuccessful balloon angioplasty [J].
Blum, U ;
Krumme, B ;
Flugel, P ;
Gabelmann, A ;
Lehnert, T ;
BuitragoTellez, C ;
Schollmeyer, P ;
Langer, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (07) :459-465
[2]   Treatment of renal angioplasty failure by percutaneous renal artery stenting with Palmaz stents: Midterm technical and clinical results [J].
Boisclair, C ;
Therasse, E ;
Oliva, VL ;
Soulez, G ;
Bui, BT ;
Querin, S ;
Robillard, P .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1997, 168 (01) :245-251
[3]   RENAL-ARTERY ANGIOPLASTY - TECHNICAL RESULTS AND CLINICAL OUTCOME IN 320 PATIENTS [J].
BONELLI, FS ;
MCKUSICK, MA ;
TEXTOR, SC ;
KOS, PB ;
STANSON, AW ;
JOHNSON, CM ;
SHEEDY, PF ;
WELCH, TJ ;
SCHIRGER, A .
MAYO CLINIC PROCEEDINGS, 1995, 70 (11) :1041-1052
[4]  
DACEY LJ, 1988, ARCH SURG-CHICAGO, V123, P1218
[5]   RENAL-ARTERY STENOSIS AND HYPERTENSION [J].
DERKX, FHM ;
SCHALEKAMP, MADH .
LANCET, 1994, 344 (8917) :237-239
[6]   SURGERY OR ANGIOPLASTY FOR COST-EFFECTIVE RENAL REVASCULARIZATION [J].
ENGLAND, WL ;
ROBERTS, SD ;
GRIM, CE .
MEDICAL DECISION MAKING, 1987, 7 (02) :84-91
[7]   Comparative analysis of percutaneous transluminal angioplasty and operation for renal revascularization [J].
Erdoes, LS ;
Berman, SS ;
Hunter, GC ;
Mills, JL .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (04) :496-503
[8]   PREVALENCE OF ISCHEMIC NEPHROPATHY IN THE ATHEROSCLEROTIC POPULATION [J].
HANSEN, KJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 24 (04) :615-621
[9]   RENAL-ARTERY STENT PLACEMENT - LONG-TERM RESULTS WITH THE WALLSTENT ENDOPROSTHESIS [J].
HENNEQUIN, LM ;
JOFFRE, FG ;
ROUSSEAU, HP ;
AZIZA, R ;
TREGANT, P ;
BERNADET, P ;
SALVADOR, M ;
CHAMONTIN, B .
RADIOLOGY, 1994, 191 (03) :713-719
[10]   HOSPITAL COSTS OF REVASCULARIZATION PROCEDURES FOR FEMOROPOPLITEAL ARTERIAL-DISEASE [J].
HUNINK, MGM ;
CULLEN, KA ;
DONALDSON, MC .
JOURNAL OF VASCULAR SURGERY, 1994, 19 (04) :632-641